Description of Competition and announcement of a possible double in share price this week.

Update the flow of the business and current events. Discussion at the end.

Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...

Preecludia | Fraud or not? This article dives into the legitimacy of Progenity's product

Description of the studies for you knowledge and how it will effect share price upon release of results

Optifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...

Itinerary for upcoming Twitter Spaces call

Clarification on the product lines for Progenity and near term catalysts in the future.

Progenity to dominate the market during end of year. Price appreciation is on the horizon due to market reevaluation and catalysts ahead.

IN THIS ISSUE Progenity This small biotechnology company has fallen from $15 a share to $1 a share in one year. We think this can go to...

IN THIS ISSUE Progenity This company is developing groundbreaking medical technology. Learn why we think now is a good time to buy....

Please subscribe to us, we are worth your time and will keep you informed! RECAP OF LAST WEEK AND RESULTS: Cassava Sciences This company...